Literature DB >> 11814479

Fucosylation of alpha1-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis.

Ingvar Rydén1, Peter Påhlsson, Arne Lundblad, Thomas Skogh.   

Abstract

BACKGROUND: Fucosylation of alpha1-acid glycoprotein (AGP, orosomucoid) has previously been found to be increased in patients with rheumatoid arthritis. Furthermore, the degree of fucosylation has been suggested to reflect disease activity. Therefore, we investigated the fucosylation of AGP in 131 patients (96 women and 35 men) with recent onset rheumatoid arthritis (RA). We compared the results with traditional biochemical markers of inflammation, i.e. plasma concentrations of AGP (P-AGP), and C-reactive protein (P-CRP).
METHODS: AGP fucosylation measured with a novel lectin enzyme-linked immunosorbent assay (ELISA) was compared with a disease activity score (DAS28) and its components, and with P-AGP, and P-CRP at the time of diagnosis, and at a follow-up visit 1 year later.
RESULTS: Both men and women with RA had increased AGP fucosylation compared to healthy individuals. We found a weak correlation between AGP fucosylation and DAS28 only in men. In men with initially increased AGP fucosylation, the level of fucosylation correlated with the change in DAS28 during the first year following diagnosis.
CONCLUSION: We conclude that AGP fucosylation is not superior to traditional markers of disease activity in RA. However, AGP fucosylation may give some additional information to traditional biochemical markers on the disease progression in men.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814479     DOI: 10.1016/s0009-8981(01)00803-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis.

Authors:  Magdalena Przybysz; Dorota Maszczak; Krzysztof Borysewicz; Jacek Szechiński; Iwona Katnik-Prastowska
Journal:  Glycoconj J       Date:  2007-07-03       Impact factor: 2.916

2.  Sialic acid residues play a pivotal role in alpha(1)-acid glycoprotein (AGP)-induced generation of reactive oxygen species in chemotactic peptide pre-activated neutrophil granulocytes.

Authors:  Peter Gunnarsson; Louise Fornander; Peter Påhlsson; Magnus Grenegård
Journal:  Inflamm Res       Date:  2009-08-11       Impact factor: 4.575

3.  Fucosylation of serum alpha1-acid glycoprotein in rheumatoid arthritis patients treated with infliximab.

Authors:  Anna Olewicz-Gawlik; Izabela Korczowska-Łacka; Jan K Łacki; Kamilla Klama; Paweł Hrycaj
Journal:  Clin Rheumatol       Date:  2007-02-20       Impact factor: 2.980

4.  Glycosylation in Autoimmune Diseases.

Authors:  Marta Ząbczyńska; Paweł Link-Lenczowski; Ewa Pocheć
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

5.  Detection of a high affinity binding site in recombinant Aleuria aurantia lectin.

Authors:  Johan Olausson; Lena Tibell; Bengt-Harald Jonsson; Peter Påhlsson
Journal:  Glycoconj J       Date:  2008-05-21       Impact factor: 2.916

6.  Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis.

Authors:  Jun Li; Hui-Chen Hsu; Yana Ding; Hao Li; Qi Wu; PingAr Yang; Bao Luo; Amber L Rowse; David M Spalding; S Louis Bridges; John D Mountz
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

7.  Jacalin bound plasma O-glycoproteome and reduced sialylation of alpha 2-HS glycoprotein (A2HSG) in rheumatoid arthritis patients.

Authors:  Ashish Saroha; Saravanan Kumar; Bishnu P Chatterjee; Hasi R Das
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

8.  In vivo clearance of alpha-1 acid glycoprotein is influenced by the extent of its N-linked glycosylation and by its interaction with the vessel wall.

Authors:  Teresa R McCurdy; Varsha Bhakta; Louise J Eltringham-Smith; Sharon Gataiance; Alison E Fox-Robichaud; William P Sheffield
Journal:  J Biomed Biotechnol       Date:  2012-04-01

Review 9.  L-fucose, a sugary regulator of antitumor immunity and immunotherapies.

Authors:  Emma Adhikari; Qian Liu; Chase Burton; Andrea Mockabee-Macias; Daniel K Lester; Eric Lau
Journal:  Mol Carcinog       Date:  2022-02-02       Impact factor: 5.139

10.  Development of a novel system for mass spectrometric analysis of cancer-associated fucosylation in plasma α1-acid glycoprotein.

Authors:  Takayuki Asao; Shin Yazawa; Toyo Nishimura; Takashi Hayashi; Hideyuki Shimaoka; Abby R Saniabadi; Hiroyuki Kuwano
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.